相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Characterization of the Impact of Merkel Cell Polyomavirus-Induced Interferon Signaling on Viral Infection
Ranran Wang et al.
JOURNAL OF VIROLOGY (2023)
How cancer cells make and respond to interferon-I
HyeonJoo Cheon et al.
TRENDS IN CANCER (2023)
DNA-methylation patterns imply a common cellular origin of virus- and UV-associated Merkel cell carcinoma
Jan Gravemeyer et al.
ONCOGENE (2022)
Viral Status Predicts the Patterns of Genome Methylation and Decitabine Response in Merkel Cell Carcinoma
Paul W. Harms et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2022)
Interferon-α and its effects on cancer cell apoptosis (Review)
Weiye Shi et al.
ONCOLOGY LETTERS (2022)
The Role of Histone Post-Translational Modifications in Merkel Cell Carcinoma
Chiara Mazziotta et al.
FRONTIERS IN ONCOLOGY (2022)
Diagnosis and treatment of Merkel cell carcinoma: European consensus-based interdisciplinary guideline - Update 2022
Marie-Lea Gauci et al.
EUROPEAN JOURNAL OF CANCER (2022)
Merkel cell carcinoma-derived exosome-shuttle miR-375 induces fibroblast polarization by inhibition of RBPJ and p53
Kaiji Fan et al.
ONCOGENE (2021)
Decoding the dynamics of multilayered stochastic antiviral IFN-I responses
Laura C. Van Eyndhoven et al.
TRENDS IN IMMUNOLOGY (2021)
Characterization of six Merkel cell polyomavirus-positive Merkel cell carcinoma cell lines: Integration pattern suggest that large T antigen truncating events occur before or during integration
David Schrama et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Hes1 attenuates type I IFN responses via VEGF-C and WDFY1
Fei Ning et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2019)
Histone deacetylase 4 promotes type I interferon signaling, restricts DNA viruses, and is degraded via vaccinia virus protein C6
Yongxu Lu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Phase I study of domatinostat (4SC-202), a class I histone deacetylase inhibitor in patients with advanced hematological malignancies
Bastian von Tresckow et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2019)
The oncogenic effects of HES1 on salivary adenoid cystic carcinoma cell growth and metastasis
Xiao-Yu Huang et al.
BMC CANCER (2018)
IFN-α induces a preferential long-lasting expression of MHC class I in human pancreatic beta cells
Alexandra Coomans de Brachene et al.
DIABETOLOGIA (2018)
Current Status of HDAC Inhibitors in Cutaneous T-cell Lymphoma
Adriana T. Lopez et al.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2018)
HDAC stimulates gene expression through BRD4 availability in response to IFN and in interferonopathies
Isabelle J. Marie et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
Circulating Cell-Free miR-375 as Surrogate Marker of Tumor Burden in Merkel Cell Carcinoma
Kaiji Fan et al.
CLINICAL CANCER RESEARCH (2018)
Regulation of type I interferon signaling in immunity and inflammation: A comprehensive review
Kun Chen et al.
JOURNAL OF AUTOIMMUNITY (2017)
Autocrine activation of the IFN signaling pathway may promote immune escape in glioblastoma
Manuela Silginer et al.
NEURO-ONCOLOGY (2017)
Stepwise assembly of functional C-terminal REST/NRSF transcriptional repressor complexes as a drug target
Ken Inui et al.
PROTEIN SCIENCE (2017)
The interference of Notch1 target Hes1 affects cell growth, differentiation and invasiveness of glioblastoma stem cells through modulation of multiple oncogenic targets
Carlo Cenciarelli et al.
Oncotarget (2017)
Merkel cell carcinoma
Juergen C. Becker et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
Epigenetic priming restores the HLA class-I antigen processing machinery expression in Merkel cell carcinoma
Cathrin Ritter et al.
SCIENTIFIC REPORTS (2017)
The transcriptional repressor Hes1 attenuates inflammation by regulating transcription elongation
Yingli Shang et al.
NATURE IMMUNOLOGY (2016)
Methyltransferase Dnmt3a upregulates HDAC9 to deacetylate the kinase TBK1 for activation of antiviral innate immunity
Xia Li et al.
NATURE IMMUNOLOGY (2016)
WDFY1 mediates TLR3/4 signaling by recruiting TRIF
Yun-Hong Hu et al.
EMBO REPORTS (2015)
Type I interferons in infectious disease
Finlay McNab et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Regulation of type I interferon responses
Lionel B. Ivashkiv et al.
NATURE REVIEWS IMMUNOLOGY (2014)
Interferons as Inducers of Apoptosis in Malignant Cells
Kevin P. Kotredes et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2013)
Type I and II IFNs Inhibit Merkel Cell Carcinoma via Modulation of the Merkel Cell Polyomavirus T Antigens
Christoph Willmes et al.
CANCER RESEARCH (2012)
Notch Signal Suppresses Toll-like Receptor-triggered Inflammatory Responses in Macrophages by Inhibiting Extracellular Signal-regulated Kinase 1/2-mediated Nuclear Factor κB Activation
Qinghua Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Transcriptome-Wide Studies of Merkel Cell Carcinoma and Validation of Intratumoral CD8+ Lymphocyte Invasion As an Independent Predictor of Survival
Kelly G. Paulson et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Trichostatin A blocks type I interferon production by activated plasmacytoid dendritic cells
Valentina Salvi et al.
IMMUNOBIOLOGY (2010)
The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
Taro Kawai et al.
NATURE IMMUNOLOGY (2010)
Hijacking HES1: how tumors co-opt the anti-differentiation strategies of quiescent cells
Liyun Sang et al.
TRENDS IN MOLECULAR MEDICINE (2010)
Integrated Regulation of Toll-like Receptor Responses by Notch and Interferon-γ Pathways
Xiaoyu Hu et al.
IMMUNITY (2008)
IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors
Kenya Honda et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Interferon-stimulated transcription and innate antiviral immunity require deacetylase activity and histone deacetylase 1
I Nusinzon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Mechanisms of Interferon-alpha induced apoptosis in malignant cells
L Thyrell et al.
ONCOGENE (2002)
A study of apoptosis in Merkel cell carcinoma - An immunohistochemical, ultrastructural, DNA ladder, and TUNEL labeling study
Y Mori et al.
AMERICAN JOURNAL OF DERMATOPATHOLOGY (2001)